Collegium Pharmaceutical (COLL) Free Cash Flow Growth (1y) (2015 - 2026)
Collegium Pharmaceutical (COLL) Free Cash Flow Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 10.34% |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn | -13.65% |
| 4 | Takeda Pharmaceutical | 27.53 Bn | 23.47 Bn | 4.39 Bn | 56.40% |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn | -5.85% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.32 Bn | 18.52 Bn | 1.16 Bn | -29.32% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 166.91% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 44.93% |
| 10 | Collegium Pharmaceutical | 1.14 Bn | 856.38 Mn | 117.25 Mn | 4.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.22% |
| Dec 31, 2025 | 44.70% |
| Sep 30, 2025 | 891.92% |
| Jun 30, 2025 | 6.80% |
| Mar 31, 2025 | -11.03% |
| Dec 31, 2024 | 16.90% |
| Sep 30, 2024 | -113.36% |
| Jun 30, 2024 | -32.01% |
| Mar 31, 2024 | 123.20% |
| Dec 31, 2023 | 11.91% |
| Sep 30, 2023 | 73.37% |
| Jun 30, 2023 | 149.23% |
| Mar 31, 2023 | 208.15% |
| Dec 31, 2022 | 83.24% |
| Sep 30, 2022 | 151.24% |
| Jun 30, 2022 | 38.81% |
| Mar 31, 2022 | -226.22% |
| Dec 31, 2021 | 69.15% |
| Sep 30, 2021 | -46.57% |
| Jun 30, 2021 | -33.04% |